Porton Pharma Solutions Ltd. Highlights of the 2023 Spanish CPHI Exhibition

Recently, the three-day 2023 Spanish CPHI exhibition came to an end. As the world's leading display platform for pharmaceutical raw materials, this exhibition attracted many pharmaceutical companies from around the world. Chongqing Porton Pharmaceutical Technology Co., Ltd. (hereinafter referred to as Porton), as one of the leading companies in China's pharmaceutical CDMO industry, continued to attend this event, demonstrating its comprehensive service capabilities in small molecule drug CDMO, large molecule drug CDMO, and gene and cell therapy CDMO required for the entire life cycle from preclinical research to drug launch.

At this exhibition, Porton Pharma Solutions Ltd. conveyed its determination to global customers and partners to firmly develop digital intelligence and promote global layout through on-site displays and interactions. Company leaders, global marketing and scientist teams also attended the event and had in-depth exchanges and discussions with exhibitors.

In terms of concurrent events, we have carefully planned a series of exciting activities. First of all, Porton has always advocated the concept of digital and intelligent production. Its Chongqing API base, as the only pharmaceutical industry factory among Chongqing's 10 innovative demonstration smart factories, has been recognized by relevant departments in 2022. During this CPHI exhibition, through on-site VR interactive experience, the audience can personally experience the on-site environment and operation process of Porton's intelligent production workshop WS109, allowing the audience to experience Porton's strong strength in digital intelligent production.